AR195097A1 - Procedimiento para la preparacion de nuevos derivados de la pirrolo(3,4-b)pirazina - Google Patents
Procedimiento para la preparacion de nuevos derivados de la pirrolo(3,4-b)pirazinaInfo
- Publication number
- AR195097A1 AR195097A1 AR246000A AR24600073A AR195097A1 AR 195097 A1 AR195097 A1 AR 195097A1 AR 246000 A AR246000 A AR 246000A AR 24600073 A AR24600073 A AR 24600073A AR 195097 A1 AR195097 A1 AR 195097A1
- Authority
- AR
- Argentina
- Prior art keywords
- pirazine
- pirrolo
- procedure
- preparation
- new derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7200505A FR2166314A1 (en) | 1972-01-07 | 1972-01-07 | 6-substd 5-(4-methyl 1-piperazinyl)carbonyloxy 7-oxo - 5,6-dihydro-pyrrolo (3,4-b)pyrazines - tranquillizers and anticonvuls |
FR7239731A FR2205318A2 (en) | 1972-11-09 | 1972-11-09 | 6-substd 5-(4-methyl 1-piperazinyl)carbonyloxy 7-oxo - 5,6-dihydro-pyrrolo (3,4-b)pyrazines - tranquillizers and anticonvuls |
Publications (1)
Publication Number | Publication Date |
---|---|
AR195097A1 true AR195097A1 (es) | 1973-09-10 |
Family
ID=26216824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR246000A AR195097A1 (es) | 1972-01-07 | 1973-01-05 | Procedimiento para la preparacion de nuevos derivados de la pirrolo(3,4-b)pirazina |
Country Status (22)
Country | Link |
---|---|
US (1) | US3862149A (no) |
JP (3) | JPS523952B2 (no) |
AR (1) | AR195097A1 (no) |
AT (1) | AT323181B (no) |
AU (1) | AU466586B2 (no) |
BE (1) | BE793730A (no) |
CA (1) | CA991183A (no) |
CY (1) | CY915A (no) |
DD (1) | DD102698A5 (no) |
DE (1) | DE2300491C3 (no) |
DK (1) | DK139359B (no) |
FI (1) | FI54124C (no) |
GB (1) | GB1358680A (no) |
HK (1) | HK60077A (no) |
HU (1) | HU164821B (no) |
IE (1) | IE37056B1 (no) |
IL (1) | IL41232A (no) |
LU (1) | LU66800A1 (no) |
NL (1) | NL7217852A (no) |
NO (1) | NO136843C (no) |
OA (1) | OA04285A (no) |
SE (1) | SE398503B (no) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR208414A1 (es) * | 1974-11-07 | 1976-12-27 | Rhone Poulenc Ind | Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2) |
FR2322601A1 (fr) * | 1975-09-04 | 1977-04-01 | Rhone Poulenc Ind | Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent |
JPS5680585A (en) * | 1979-11-30 | 1981-07-01 | Toyoda Gosei Kk | High pressure hose |
JPS57144860A (en) * | 1981-03-04 | 1982-09-07 | Matsushita Electric Ind Co Ltd | Secondary side water pressure controller for water cooler |
DE3378763D1 (en) * | 1982-04-02 | 1989-02-02 | Takeda Chemical Industries Ltd | Condensed pyrrolinone derivatives, and their production |
JPS6169773A (ja) * | 1984-09-14 | 1986-04-10 | Takeda Chem Ind Ltd | イソインドリノン誘導体 |
JPS6297400U (no) * | 1985-12-09 | 1987-06-20 | ||
FR2607504B1 (fr) * | 1986-12-02 | 1989-01-27 | Rhone Poulenc Sante | Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent |
FR2671800B1 (fr) * | 1991-01-17 | 1993-03-12 | Rhone Poulenc Rorer Sa | Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent. |
US5786357A (en) | 1991-12-02 | 1998-07-28 | Sepracor Inc. | Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone |
AU3275993A (en) * | 1991-12-02 | 1993-06-28 | Sepracor, Inc. | Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (-) zopiclone |
WO1993010787A1 (en) * | 1991-12-02 | 1993-06-10 | Sepracor, Inc. | Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone |
CA2332521C (en) | 1998-06-09 | 2009-02-10 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for treating or preventing sleep disorders |
US6339086B1 (en) | 1999-05-14 | 2002-01-15 | Swpracor, Inc. | Methods of making and using N-desmethylzopiclone |
ES2203319B1 (es) * | 2002-04-03 | 2005-03-01 | Universidad De Oviedo | Nuevos carbonatos opticamente activos como intermedios en la sintesis de (+)-zopiclona. |
DK1691811T3 (da) | 2003-12-11 | 2014-10-20 | Sunovion Pharmaceuticals Inc | Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression |
MX2008000249A (es) * | 2005-07-06 | 2008-03-18 | Sepracor Inc | Combinaciones de eszopiclona y o-desmetilvenlafaxina y metodos de tratamiento de menopausia y trastornos del estado de animo, ansiedad y cognitivos. |
EP1904066B1 (en) | 2005-07-06 | 2018-05-23 | Sunovion Pharmaceuticals Inc. | COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS |
CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
US7476737B2 (en) * | 2005-09-05 | 2009-01-13 | Dr. Reddy's Laboratories Limited | Eszopiclone process |
WO2007047978A2 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
EP2314289A1 (en) | 2005-10-31 | 2011-04-27 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20070203145A1 (en) * | 2006-02-03 | 2007-08-30 | Jie Zhu | Zopiclone resolution |
US20070244143A1 (en) * | 2006-03-08 | 2007-10-18 | Braincells, Inc | Modulation of neurogenesis by nootropic agents |
US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
WO2007109799A2 (en) * | 2006-03-23 | 2007-09-27 | Teva Pharmaceutical Industries Ltd. | Polymorphs of eszopiclone malate |
US20070270590A1 (en) * | 2006-04-20 | 2007-11-22 | Marioara Mendelovici | Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone |
CN101058581B (zh) * | 2006-04-21 | 2011-06-08 | 天津天士力集团有限公司 | 右佐匹克隆中间体6-(5-氯-2-吡啶基)-5,7-二氧代-6,7-二氢-5H-吡咯并[3,4-b]吡嗪的制备方法 |
CA2651813A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
US7678808B2 (en) * | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
EP1904499A1 (en) * | 2006-06-26 | 2008-04-02 | Teva Pharmaceutical Industries Ltd | Process for the preparation of zopiclone |
EP2068872A1 (en) * | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
CA2663347A1 (en) * | 2006-09-19 | 2008-03-27 | Braincells, Inc. | Ppar mediated modulation of neurogenesis |
US7786304B2 (en) * | 2006-11-06 | 2010-08-31 | Centaur Pharmaceutical Pvt. Ltd. | Process for the preparation of eszopiclone |
EP2032557A2 (en) * | 2007-01-31 | 2009-03-11 | Teva Pharmaceutical Industries Ltd. | Methods for preparing eszopiclone |
US20080305171A1 (en) * | 2007-06-07 | 2008-12-11 | Kristin Anne Arnold | Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there |
US20090018336A1 (en) * | 2007-06-25 | 2009-01-15 | Nina Finkelstein | Racemization process of R-zopiclone |
EP2020403A1 (en) | 2007-08-02 | 2009-02-04 | Esteve Quimica, S.A. | Process for the resolution of zopiclone and intermediate compounds |
WO2009063486A2 (en) * | 2007-08-06 | 2009-05-22 | Usv Limited | Process for preparation of dextrorotatory isomer of 6-(5-chloro-pyrid-2-yi)-5-[(4-methyl -1-piperazinyl) carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo [3,4-b] pyrazine (eszopiclone) |
AU2008346110A1 (en) * | 2007-12-11 | 2009-07-16 | Cipla Ltd. | Crystalline polymorphic forms of zopiclone, processes for their preparation and their pharmaceutical compositions |
CA2812705C (en) * | 2007-12-19 | 2015-08-18 | Sunovion Pharmaceuticals Inc. | Maleate, besylate and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
US8269005B2 (en) * | 2007-12-19 | 2012-09-18 | Sunovion Pharmaceuticals Inc. | L-malate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-Oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US8198278B2 (en) | 2007-12-19 | 2012-06-12 | Sunovion Pharmaceuticals Inc. | Besylate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
WO2009085988A1 (en) * | 2007-12-19 | 2009-07-09 | Sepracor Inc. | Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7- dihydro-5h-pyrrolo[3,4-b]pyrazine |
CN100467471C (zh) * | 2007-12-19 | 2009-03-11 | 齐鲁天和惠世制药有限公司 | 佐匹克隆的制备方法 |
US8198277B2 (en) | 2007-12-19 | 2012-06-12 | Sunovion Pharmaceuticals Inc. | L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US8212036B2 (en) * | 2007-12-19 | 2012-07-03 | Sunovion Pharmaceuticals Inc. | Maleate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US8268832B2 (en) * | 2007-12-19 | 2012-09-18 | Sunovion Pharmaceuticals Inc. | Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
EP2391354B1 (en) | 2009-01-30 | 2019-11-27 | Sunovion Pharmaceuticals Inc. | Coated tablets of 6-(5-chloro-2-pyridyl) -5-[ (4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6, 7-dihydro-5h-pyrrol o [3,4-b] pyrazine and process for preparation thereof |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
CN105399745A (zh) * | 2015-12-17 | 2016-03-16 | 天津华津制药有限公司 | 一种吡嗪并羟基吡咯烷酮类化合物的制备方法 |
WO2017214442A1 (en) | 2016-06-08 | 2017-12-14 | President And Fellows Of Harvard College | Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, rett syndrome, and fragile x syndrome |
CN106220630B (zh) * | 2016-07-23 | 2019-12-10 | 迪嘉药业集团有限公司 | 一种n-取代吡咯并[3,4-b]吡嗪-5,7(6h)-二酮的制备方法 |
CA3099791A1 (en) * | 2018-05-29 | 2019-12-05 | President And Fellows Of Harvard College | Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment |
US12077512B2 (en) | 2019-03-25 | 2024-09-03 | President And Fellows Of Harvard College | Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment |
-
1972
- 1972-12-14 OA OA54780A patent/OA04285A/xx unknown
- 1972-12-28 DD DD167951A patent/DD102698A5/xx unknown
- 1972-12-29 US US319876A patent/US3862149A/en not_active Expired - Lifetime
- 1972-12-29 NL NL7217852A patent/NL7217852A/xx unknown
-
1973
- 1973-01-04 AU AU50754/73A patent/AU466586B2/en not_active Expired
- 1973-01-04 IE IE12/73A patent/IE37056B1/xx unknown
- 1973-01-04 IL IL41232A patent/IL41232A/xx unknown
- 1973-01-04 HU HURO691A patent/HU164821B/hu unknown
- 1973-01-05 AT AT10073A patent/AT323181B/de active
- 1973-01-05 CY CY915A patent/CY915A/xx unknown
- 1973-01-05 DK DK6973AA patent/DK139359B/da not_active IP Right Cessation
- 1973-01-05 AR AR246000A patent/AR195097A1/es active
- 1973-01-05 CA CA160,620A patent/CA991183A/fr not_active Expired
- 1973-01-05 JP JP48000069A patent/JPS523952B2/ja not_active Expired
- 1973-01-05 BE BE793730D patent/BE793730A/xx active Protection Beyond IP Right Term
- 1973-01-05 DE DE2300491A patent/DE2300491C3/de not_active Expired
- 1973-01-05 SE SE7300159A patent/SE398503B/xx active Protection Beyond IP Right Term
- 1973-01-05 FI FI27/73A patent/FI54124C/fi active
- 1973-01-05 GB GB79073A patent/GB1358680A/en not_active Expired
- 1973-01-05 LU LU66800A patent/LU66800A1/xx unknown
- 1973-01-05 NO NO62/73A patent/NO136843C/no unknown
-
1976
- 1976-09-08 JP JP51106832A patent/JPS5248688A/ja active Granted
- 1976-09-08 JP JP51106831A patent/JPS5248687A/ja active Granted
-
1977
- 1977-12-01 HK HK600/77A patent/HK60077A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US3862149A (en) | 1975-01-21 |
DK139359B (da) | 1979-02-05 |
NO136843B (no) | 1977-08-08 |
JPS5248688A (en) | 1977-04-18 |
HK60077A (en) | 1977-12-09 |
NL7217852A (no) | 1973-07-10 |
GB1358680A (en) | 1974-07-03 |
BE793730A (fr) | 1973-07-05 |
HU164821B (no) | 1974-04-11 |
FI54124B (fi) | 1978-06-30 |
AU5075473A (en) | 1974-07-04 |
JPS523952B2 (no) | 1977-01-31 |
JPS5231358B2 (no) | 1977-08-13 |
IL41232A (en) | 1975-12-31 |
JPS535315B2 (no) | 1978-02-25 |
JPS4876892A (no) | 1973-10-16 |
CA991183A (fr) | 1976-06-15 |
IE37056L (en) | 1973-07-07 |
AU466586B2 (en) | 1975-10-30 |
NO136843C (no) | 1977-11-16 |
CY915A (en) | 1977-12-23 |
DE2300491B2 (de) | 1977-09-08 |
JPS5248687A (en) | 1977-04-18 |
SE398503B (sv) | 1977-12-27 |
OA04285A (fr) | 1979-12-31 |
FI54124C (fi) | 1978-10-10 |
DD102698A5 (no) | 1973-12-20 |
DE2300491A1 (de) | 1973-07-19 |
AT323181B (de) | 1975-06-25 |
LU66800A1 (no) | 1973-07-18 |
DK139359C (no) | 1979-07-09 |
IL41232A0 (en) | 1973-03-30 |
DE2300491C3 (de) | 1978-05-18 |
IE37056B1 (en) | 1977-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR195097A1 (es) | Procedimiento para la preparacion de nuevos derivados de la pirrolo(3,4-b)pirazina | |
AR195412A1 (es) | Procedimiento para la preparacion de derivados de 4-difenilmetil- y 4-difenilmetilenpiperidino | |
AR205611A1 (es) | Procedimiento para la preparacion de derivados de 3-fenoxi-2-hidroxi-propilamina | |
AR204926A1 (es) | Procedimiento para la preparacion de 2,2,6,6-tetrametil-4-oxopiperidina | |
AR200007A1 (es) | Procedimiento para la preparacion de nuevos oxazoles 2,4,5-trisustituidos | |
AR219038A1 (es) | Procedimiento para la preparacion de derivados de 1-hidroxi-2-piridonas-6-substituidas | |
AR192232A1 (es) | Procedimiento para la preparacion de nuevos derivados de 1,2,3,4-tetrahidroisoquinolina | |
AR208393A1 (es) | Procedimiento para la preparacion de 2,2,6,6-tetrametil-4-oxopiperidina | |
AR207744A1 (es) | Procedimiento para la preparacion de nuevos derivados de isotiocianopiridinas | |
AR203090A1 (es) | Procedimiento para la preparacion de derivados de hexahidro-pirimidino-dibenzo-azepina | |
AR202283A1 (es) | Procedimiento para la preparacion de derivados de 1-piperidinsulfonilurea | |
AR205437A1 (es) | Procedimiento para la preparacion de derivados de indoloquinolinona | |
AR200162A1 (es) | Procedimiento para la preparacion de derivados 1,2,4-triazolicos | |
AR201114A1 (es) | Procedimiento para la elaboracion de nuevas aza -10,11-dihidro 5-h-dibenzo<b,e>-<1,4>-diazepinas | |
AR208055A1 (es) | Procedimiento para la preparacion de nuevos derivados de 2-amino-5,6-dihidro-pirazolo(5,1-a)-isoquinolinas | |
AR200576A1 (es) | Procedimiento para la preparacion de derivados pirazolicos | |
AR201427A1 (es) | Procedimiento para la preparacion de derivados de cefalosprina | |
AR203388A1 (es) | Procedimiento para la preparacion de derivados de 2-metoxicarbonilamino-imidazo(4,5-b)piridina | |
AR207633Q (es) | Procedimiento para la elaboracion de nuevos derivados de 2-benzoil-3-amino-6-cloro-piridinas | |
AR205800A1 (es) | Procedimiento para la preparacion de nuevos derivados de 3,4-difenil-imidazolina | |
AR209616A1 (es) | Procedimiento para la preparacion de derivados de 17alpha-aciloxi-d-homo-pregn-4-eno-3,20-diona | |
AR202001A1 (es) | Procedimiento para la preparacion de derivados de 3,5-diyodosalicilanilidas | |
AR204327A1 (es) | Procedimiento para la preparacion de derivados de 1,2,3,4-tetrahidroisoquinolina | |
AR195837A1 (es) | Procedimiento para la preparacion de derivados de ciclopenteno-quinolona | |
AR197242A1 (es) | Procedimiento para la preparacion de derivados de n-isopropil-1-metilamino-3-(1-naftoxi)-2-propanol |